Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2853 results found
2025 ∙ Li, S. Li, R. Li, Y. Hu, Y. Liu, Y. Qin, J. Qin, Z. Feng, Q. Sheng, Z. Li, C. Peng, J.
Combination of Evans syndrome and COVID-19: a systematic review of reported cases
All age groups COVID-19 Safety
Rating:
Critically low
2025 ∙ Jwa, S. Imanishi, Y. Ascher, M. T. Dudley, M. Z.
Communication interventions to reduce parental vaccine hesitancy: A systematic review
Parents/caregivers Newborn Children Acceptance
Rating:
Not applicable
2025 ∙ Iannizzi, C. Andreas, M. Bohndorf, E. Hirsch, C. Zorger, A. M. Brinkmann-Paulukat, J. Bormann, B. Kaufman, J. Lischetzki, T. Monsef, I. Neufeind, J. Schmid-Kupke, N. Thole, S. Worbes, K. Skoetz, N.
Communication-based interventions to increase COVID-19 vaccine willingness and uptake: A systematic review with meta-analysis
All age groups COVID-19 Coverage Acceptance
Rating:
Not applicable
2025 ∙ Kong, F. Cai, L. Zhang, J. Zhu, H. Peng, Z. Zheng, J. Zheng, Y. Fang, H.
Comparative Analysis of Health Economic Evaluations for Different Influenza Vaccines and Vaccination Strategies in China: A Systematic Review
Western Pacific China All age groups Pregnant women Influenza Economic aspects
Rating:
Not applicable
2025 ∙ Wang, X. Pahwa, A. Bausch-Jurken, M. T. Chitkara, A. Sharma, P. Malmenas, M. Vats, S. Whitfield, M. G. Lai, K. Z. H. Dasari, P. Gupta, R. Nassim, M. Van de Velde, N. Green, N. Beck, E.
Comparative Effectiveness of mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Adults with Underlying Medical Conditions: Systematic Literature Review and Pairwise Meta-Analysis Using GRADE
Adults Older adults COVID-19 Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Fahrbach, K. Cichewicz, A. Chu, H. Di Fusco, M. Burnett, H. Volkman, H. R. Akin-Fajiye, M. Mendoza, C. F. Cappelleri, J. C.
Comparative effectiveness of Omicron XBB 1.5-adapted COVID-19 vaccines: a systematic literature review and network meta-analysis
All age groups COVID-19 Efficacy/effectiveness Administration Safety
Rating:
Critically low
2025 ∙ Syed, A. A. Eqbal, F. Shamsi, H. R. Syed, A. R. S. Zakir, S. J. Fawzy, M. Khan, K. S.
Comparative effectiveness of three common SARS-COV-2 vaccines: A network meta-analysis of randomized trials
All age groups COVID-19 Efficacy/effectiveness Safety Administration
Rating:
Moderate
2025 ∙ Rai, S. Tripathi, S.
Comparative efficacy of leading COVID-19 vaccines: A netwometa-analysis
All age groups COVID-19 Efficacy/effectiveness Administration
Rating:
Low
2025 ∙ Santos, S. A. D. Sato, M. Y. Basilio, P. H. G. Pereira, M. E. Juliao, R. C. Arruda, N. D. C. Silva, D. P. D. Oliveira, C. S. Costa-Junior, V. H. D. S. Guiloski, I. C.
Comparison between the safety of the HPV vaccine versus placebo: a systematic review and meta-analysis of randomized clinical trials
Adolescents Adults Human papillomavirus (HPV) Safety
Rating:
Low
2025 ∙ Fletcher, M. A. Okasha, O. Baay, M. Syrochkina, M. Hayford, K.
Complicated pneumococcal pneumonia in the era of higher-valent pneumococcal conjugate vaccines: a systematic literature review and meta-analysis, 2001-2022
All age groups Pneumococcal disease Administration Efficacy/effectiveness
Rating:
Critically low
Loading...